Work

Temozolomide (TMZ) plus thalidomide (THAL) as adjuvant therapy in patients with stage III and stage IV malignant melanoma

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.7574

Authors: W.-J. Hwu, D. Coit, D. Jaques, K. S. Panageas, L. A. Lamb, C. J. Quinn

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2245468844

Cites:

Cited by:

Related to: 10